Grail (GRAL) Shares Outstanding (Weighted Average) (2023 - 2026)
Grail (GRAL) reported Shares Outstanding (Weighted Average) of $40.6 million for Q1 2026, up 18.46% on a YoY basis from $34.3 million in Q1 2025, and up 10.58% quarter-over-quarter from $36.8 million in Q4 2025.
Grail (GRAL) Shares Outstanding (Weighted Average) (2023 - 2026) Analysis & Trends
Grail has reported Shares Outstanding (Weighted Average) for 4 years, with the latest figure at $40.6 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 18.46% year-over-year to $40.6 million; the trailing twelve-month figure through Mar 2026 stood at $40.6 million (up 18.46% YoY), and the FY2025 full-year result was $36.8 million, up 15.21% from the prior year.
- Shares Outstanding (Weighted Average) for Q1 2026 stood at $40.6 million, up from $36.8 million in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $40.6 million in Q1 2026, with the low at $31.0 million in Q2 2023.
- Historically, Shares Outstanding (Weighted Average) has averaged $33.5 million across 4 years, with a median of $31.9 million in 2024.
- Annual changes were most pronounced in 2024 — Shares Outstanding (Weighted Average) changed 0.0% — and 2026, when it climbed 18.46%.
- Grail's Shares Outstanding (Weighted Average) stood at $31.0 million in 2023, then increased by 2.74% to $31.9 million in 2024, then gained by 15.21% to $36.8 million in 2025, then advanced by 10.58% to $40.6 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $40.6 million (Q1 2026), $36.8 million (Q4 2025), and $35.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 82.14 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 372.00 Mn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 707.90 Mn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 79.65 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 282.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 168.40 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 141.50 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 153.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 20.29 Mn |
| 10 | Grail | 2.49 Bn | 2.49 Bn | 10.12 Mn | 40.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.64 Mn |
| Dec 31, 2025 | 36.75 Mn |
| Sep 30, 2025 | 35.42 Mn |
| Jun 30, 2025 | 35.79 Mn |
| Mar 31, 2025 | 34.31 Mn |
| Dec 31, 2024 | 31.90 Mn |
| Sep 30, 2024 | 31.88 Mn |
| Jun 30, 2024 | 31.05 Mn |
| Mar 31, 2024 | 31.05 Mn |
| Dec 31, 2023 | 31.05 Mn |
| Oct 1, 2023 | 31.05 Mn |
| Jun 30, 2023 | 31.05 Mn |